CHICAGO (December 18, 2017) – Women in Listed Derivatives (WILD), an organization which promotes career advancement and professional relationship-building among women in the OTC & Listed Derivatives Industry, today announced new additions to its board of directors.

The North American chapter of WILD announced that Katie Cleland, Global Head of Data, Analytics, and Client Reporting IT at Societe Generale, Elizabeth Cook, Board of Directors at CME Group, Caroline Gillard, Public Relations Specialist at OCC, Ellen Greene, Managing Director at SIFMA, and Leslie Sutphen, President of Financial Markets Consulting, LLC, will fill five open board seats. They join sitting board members: Karen Chhokar, Cathey Curley, Natalie Oblazny, Erin Preston, Diane Saucier and Adrienne White.

The 2018 Board of Directors will oversee events, membership, mentorship programs and charitable activities as well as look for new ways to promote the advancement of women in the industry. Board members serve two-year terms on a staggered basis.

WILD began informally in 2009 and first established its board in 2012. As a non-profit, WILD promotes career advancement and professional relationship-building among women in the OTC & Listed Derivatives Industry through social and educational events and whose mission it is to highlight and learn from industry role models, encourage career development and support the advancement of women in OTC & Listed Derivatives. More information can be found at www.womeninlistedderivatives.org